Product Program year 2024 Source: CMS Open Payments

Omnilink Elite

Device Vascular

PDI 08717648179563

Open in the dashboard

General payments

$309,736

1,517 payments

Research payments

$0

0 payments

Through program year 2024, $309,736 in general payments and $0 in research payments were reported against Omnilink Elite (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $421 22
2023 General $16,531 48
2022 General $292,784 1,447

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $309,736 1,517 payments
Top recipients General payments · program year 2024
  1. Scott Laura Interventional Cardiology · New Orleans, LA $32 8% · 1 payment
  2. Gonzalo Obnial Vascular Surgery · Walnut Creek, CA $29 7% · 1 payment
  3. Rajiv Nagesetty Vascular Surgery · Walnut Creek, CA $29 7% · 1 payment
  4. Romel Velastegui Rancho Cordova, CA $27 6% · 1 payment
  5. Jonathan Greifenkamp Cardiovascular Disease · Longview, TX $26 6% · 2 payments

The top 5 of 20 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Vascular Surgery Surgery $184 47% · 9 practitioners
  2. Interventional Cardiology Internal Medicine $77 19% · 4 practitioners
  3. Cardiovascular Disease Internal Medicine $73 19% · 3 practitioners
  4. Nurse Anesthetist, Certified Registered $25 6% · 1 practitioner
  5. Vascular & Interventional Radiology Radiology $21 5% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $131 31% · 6 recipients
  2. Texas $69 16% · 3 recipients
  3. Tennessee $61 15% · 3 recipients
  4. Louisiana $32 8% · 1 recipient
  5. New York $29 7% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

1,517 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record